Associations between the polymorphisms of main components in PI3K/Akt pathway and risk of diabetic kidney disease: A

Hang Fu1,2, Congcong Guo2, Jing Zhang3

  • 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

IUBMB Life
|March 1, 2023
PubMed
Abstract

Insights

This meta-analysis found that specific polymorphisms in the PI3K/Akt pathway, particularly in eNOS and IL-6 genes, are linked to an increased risk of diabetic kidney disease (DKD). These genetic variations may contribute to DKD susceptibility in diabetic patients.

Area of Science:

  • Genetics and Molecular Biology
  • Nephrology
  • Endocrinology

Background:

  • Diabetic kidney disease (DKD) is a serious complication of diabetes, significantly increasing morbidity and mortality.
  • The phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) pathway plays a crucial role in cellular processes relevant to DKD pathogenesis.
  • Understanding the genetic underpinnings of DKD susceptibility is vital for developing targeted prevention and treatment strategies.

Approach:

  • A comprehensive meta-analysis was conducted, systematically searching major scientific databases for relevant case-control studies.
  • Fifty-two eligible studies encompassing seven single nucleotide polymorphisms (SNPs) across four genes (GNB3, eNOS, IL-6, TNFα) within the PI3K/Akt pathway were included.
  • Statistical analyses, including heterogeneity testing, were performed using Review Manager 5.4 to synthesize the findings.

Key Points:

  • Polymorphisms in eNOS (rs1799983, rs869109213, rs2070744) and IL-6 (rs1800796) within the PI3K/Akt pathway were significantly associated with an increased risk of DKD.
  • The 'M' allele of eNOS rs1799983 showed a 29% increased DKD risk overall and a 50% increase in the Asian population.
  • The 'M' allele of IL-6 rs1800796 was predominantly associated with higher DKD risks, particularly in the Asian population, with a 49% increased risk overall.

Conclusions:

  • Specific PI3K/Akt pathway gene polymorphisms, notably in eNOS and IL-6, are implicated as risk factors for developing diabetic kidney disease.
  • These genetic associations highlight the PI3K/Akt pathway's role in DKD pathogenesis and suggest potential targets for future research.
  • The findings underscore the importance of considering genetic predisposition in the context of diabetes management and DKD prevention.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
224
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.8K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
66